Targeted prostate cancer screening in BRCA1 and BRCA2 mutation carriers: results from the initial screening round of the IMPACT study.

Saved in:
Bibliographic Details
Title: Targeted prostate cancer screening in BRCA1 and BRCA2 mutation carriers: results from the initial screening round of the IMPACT study.
Authors: Bancroft EK; Cancer Genetics Unit and Academic Urology Unit, Royal Marsden NHS Foundation Trust, London, UK; Oncogenetics Team, Institute of Cancer Research, London, UK., Page EC; Oncogenetics Team, Institute of Cancer Research, London, UK., Castro E; Oncogenetics Team, Institute of Cancer Research, London, UK; Spanish National Cancer Research Centre, Madrid, Spain., Lilja H; Departments of Laboratory Medicine, Surgery, and Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA; Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK; Institute of Biomedical Technology, University of Tampere, Tampere, Finland; Department of Laboratory Medicine, Lund University, Malmö, Sweden., Vickers A; Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, NY, USA., Sjoberg D; Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, NY, USA., Assel M; Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, NY, USA., Foster CS; HCA Healthcare Laboratories, London, WC1E 6JA, UK., Mitchell G; Familial Cancer Centre, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia., Drew K; Familial Cancer Centre, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia., Mæhle L; Norwegian Radium Hospital, Oslo, Norway., Axcrona K; Norwegian Radium Hospital, Oslo, Norway., Evans DG; Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK., Bulman B; Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK., Eccles D; Wessex Clinical Genetics Service, Princess Anne Hospital, Southampton, UK., McBride D; Wessex Clinical Genetics Service, Princess Anne Hospital, Southampton, UK., van Asperen C; Leiden University Medical Center, Leiden, The Netherlands., Vasen H; Foundation for the Detection of Hereditary Tumours, Leiden, The Netherlands., Kiemeney LA; Radboud University Medical Centre, Nijmegen, The Netherlands., Ringelberg J; Foundation for the Detection of Hereditary Tumours, Leiden, The Netherlands., Cybulski C; International Hereditary Cancer Center, Pomeranian Medical University, Szczecin, Poland., Wokolorczyk D; International Hereditary Cancer Center, Pomeranian Medical University, Szczecin, Poland., Selkirk C; Center for Medical Genetics, NorthShore University HealthSystem, Evanston, IL, USA., Hulick PJ; Center for Medical Genetics, NorthShore University HealthSystem, Evanston, IL, USA; Priztker School of Medicine, University of Chicago, Chicago, IL, USA., Bojesen A; Vejle Hospital, Vejle, Denmark., Skytte AB; Vejle Hospital, Vejle, Denmark., Lam J; Department of Urology, Repatriation General Hospital, Daw Park, South Australia, Australia., Taylor L; Department of Urology, Repatriation General Hospital, Daw Park, South Australia, Australia., Oldenburg R; Erasmus Medical Center, Rotterdam, The Netherlands., Cremers R; Radboud University Medical Centre, Nijmegen, The Netherlands., Verhaegh G; Radboud University Medical Centre, Nijmegen, The Netherlands., van Zelst-Stams WA; Radboud University Medical Centre, Nijmegen, The Netherlands., Oosterwijk JC; University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., Blanco I; Hereditary Cancer Program, Catalonian Institute of Oncology, L'Hospitalet, Barcelona, Spain., Salinas M; Hereditary Cancer Program, Catalonian Institute of Oncology, L'Hospitalet, Barcelona, Spain., Cook J; Sheffield Clinical Genetics Service, Sheffield Children's Hospital, Sheffield, UK., Rosario DJ; Royal Hallamshire Hospital, Sheffield, UK., Buys S; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA., Conner T; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA., Ausems MG; Department of Medical Genetics, University Medical Centre Utrecht, The Netherlands., Ong KR; Clinical Genetics Unit, Birmingham Women's Hospital, Birmingham, UK., Hoffman J; Clinical Genetics Unit, Birmingham Women's Hospital, Birmingham, UK., Domchek S; Basser Research Center, University of Pennsylvania, Philadelphia, PA, USA., Powers J; Basser Research Center, University of Pennsylvania, Philadelphia, PA, USA., Teixeira MR; Genetics Department and Research Center, Portuguese Oncology Institute, Porto, Portugal; Biomedical Sciences Institute (ICBAS), Porto University, Porto, Portugal., Maia S; Genetics Department and Research Center, Portuguese Oncology Institute, Porto, Portugal., Foulkes WD; McGill Program in Cancer Genetics, Departments of Oncology and Human Genetics, McGill University, Montreal, Quebec, Canada., Taherian N; McGill Program in Cancer Genetics, Departments of Oncology and Human Genetics, McGill University, Montreal, Quebec, Canada., Ruijs M; The Netherlands Cancer Institute, Amsterdam, The Netherlands., Helderman-van den Enden AT; Maastricht University Medical Center, Department of Clinical Genetics, Maastricht, The Netherlands., Izatt L; South East Thames Genetics Service, London, UK, Guy's Hospital, London, UK., Davidson R; Duncan Guthrie Institute of Medical Genetics, Yorkhill NHS Trust, Glasgow, UK., Adank MA; VU University Medical Center, Amsterdam, The Netherlands., Walker L; Churchill Hospital, Headington, Oxford, UK., Schmutzler R; Center of Familial Breast and Ovarian Cancer, University Hospital of Cologne, Cologne, Germany., Tucker K; Hereditary Cancer Clinic, Prince of Wales Hospital, Randwick, New South Wales, Australia; Faculty of Medicine, University of New South Wales, Sydney, New South Wales, Australia., Kirk J; Familial Cancer Service, Westmead Hospital, Westmead, Sydney, New South Wales, Australia; Sydney Medical School (University of Sydney) at Westmead Millennium Institute, Sydney, NSW, Australia., Hodgson S; St. George's Hospital, Tooting, London, UK., Harris M; Familial Cancer Centre, Monash Health, Clayton, Victoria, Australia., Douglas F; Northern Genetics Service, Newcastle upon Tyne Hospitals, Newcastle upon Tyne, UK., Lindeman GJ; Familial Cancer Centre, The Royal Melbourne Hospital, Parkville, Victoria, Australia; Stem Cells and Cancer Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia; Department of Medicine, The University of Melbourne, Parkville, Victoria, Australia., Zgajnar J; Institute of Oncology, Ljubljana, Slovenia., Tischkowitz M; Addenbrooke's Hospital, Cambridge, UK; The University of Cambridge, Cambridge, UK., Clowes VE; Addenbrooke's Hospital, Cambridge, UK; The University of Cambridge, Cambridge, UK., Susman R; Genetic Health Queensland, Royal Brisbane and Women's Hospital, Herston, Queensland, Australia., Ramón y Cajal T; Hospital de Sant Pau, Barcelona, Spain., Patcher N; Genetic Services of WA, King Edward Memorial Hospital, Subiaco, WA, Australia; Department of Paediatrics, University of Western Australia, Perth, WA, Australia., Gadea N; Hospital Vall d'Hebron, Barcelona, Spain., Spigelman A; Hunter Family Cancer Service, Waratah, New South Wales, Australia; University of New South Wales, St. Vincent's Clinical School, Darlinghurst, New South Wales, Australia; Hereditary Cancer Clinic, The Kinghorn Cancer Centre, St. Vincent's Hospital, Sydney, New South Wales, Australia., van Os T; Academic Medical Center, Amsterdam, The Netherlands., Liljegren A; Karolinska University Hospital and Karolinska Institute, Stockholm, Sweden., Side L; NE Thames Regional Genetics Service, Institute of Child Health, London, UK., Brewer C; Peninsular Genetics, Derriford Hospital, Plymouth, UK; Royal Devon and Exeter Hospital, Exeter, UK., Brady AF; North West Thames Regional Genetics Service, Kennedy-Galton Centre, North West London Hospitals NHS Trust, Harrow, UK., Donaldson A; St. Michael's Hospital, Bristol, UK., Stefansdottir V; Landspitali-the National University Hospital of Iceland, Reykjavik, Iceland., Friedman E; Chaim Shema Medical Center, Tel-Hashomer, Israel., Chen-Shtoyerman R; The Genetic Institute, Kaplan Medical Center, Rehovot, Israel., Amor DJ; Murdoch Childrens Research Institute, Parkville, Victoria, Australia., Copakova L; National Cancer Institute, Bratislava, Slovak Republic., Barwell J; University of Leicester, Leicester, UK; University Hospitals Leicester, Leicester, UK., Giri VN; Fox Chase Cancer Center, Philadelphia, PA, USA., Murthy V; Tata Memorial Centre, Mumbai, India., Nicolai N; Istituto Nazionale dei Tumori, Milano, Italy., Teo SH; Cancer Research Initiatives Foundation, Subang Jaya Medical Centre, Selangor, Darul Ehsan, Malaysia., Greenhalgh L; Clinical Genetics, Royal Liverpool Children's Hospital, Liverpool, UK., Strom S; The University of Texas, MD Anderson Cancer Center, Houston, TX, USA., Henderson A; Northern Genetics Service, Newcastle upon Tyne Hospitals, Newcastle upon Tyne, UK., McGrath J; Royal Devon and Exeter Hospital, Exeter, UK., Gallagher D; Mater Misericordiae University Hospital, Dublin, Ireland., Aaronson N; The Netherlands Cancer Institute, Amsterdam, The Netherlands., Ardern-Jones A; Cancer Genetics Unit and Academic Urology Unit, Royal Marsden NHS Foundation Trust, London, UK., Bangma C; Erasmus Medical Center, Rotterdam, The Netherlands., Dearnaley D; Cancer Genetics Unit and Academic Urology Unit, Royal Marsden NHS Foundation Trust, London, UK; Oncogenetics Team, Institute of Cancer Research, London, UK., Costello P; Wessex Clinical Genetics Service, Princess Anne Hospital, Southampton, UK., Eyfjord J; Faculty of Medicine, School of Health Sciences, University of Iceland, Reykjavik, Iceland., Rothwell J; Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK., Falconer A; Imperial College Healthcare NHS Trust, London, London, UK., Gronberg H; University Hospital, Umea, Sweden., Hamdy FC; Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK; Churchill Hospital, Headington, Oxford, UK., Johannsson O; Landspitali-the National University Hospital of Iceland, Reykjavik, Iceland., Khoo V; Cancer Genetics Unit and Academic Urology Unit, Royal Marsden NHS Foundation Trust, London, UK., Kote-Jarai Z; Oncogenetics Team, Institute of Cancer Research, London, UK., Lubinski J; International Hereditary Cancer Center, Pomeranian Medical University, Szczecin, Poland., Axcrona U; Norwegian Radium Hospital, Oslo, Norway., Melia J; The University of Cambridge, Cambridge, UK., McKinley J; Familial Cancer Centre, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia., Mitra AV; Oncogenetics Team, Institute of Cancer Research, London, UK; University College London Hospitals NHS Foundation Trust, London, UK., Moynihan C; Oncogenetics Team, Institute of Cancer Research, London, UK., Rennert G; CHS National Cancer Control Center, Carmel Medical Center, Haifa, Israel., Suri M; Nottingham City Hospital, Nottingham, UK., Wilson P; BioZenix, Altrincham, Cheshire, UK., Killick E; Cancer Genetics Unit and Academic Urology Unit, Royal Marsden NHS Foundation Trust, London, UK; Oncogenetics Team, Institute of Cancer Research, London, UK., Moss S; Queen Mary University of London, London, UK., Eeles RA; Oncogenetics Team, Institute of Cancer Research, London, UK; Cancer Genetics Unit and Academic Urology Unit, Royal Marsden NHS Foundation Trust, London, UK. Electronic address: rosalind.eeles@icr.ac.uk.
Corporate Authors: IMPACT Collaborators
Source: European urology [Eur Urol] 2014 Sep; Vol. 66 (3), pp. 489-99. Date of Electronic Publication: 2014 Jan 15.
Publication Type: Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier Science Country of Publication: Switzerland NLM ID: 7512719 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-7560 (Electronic) Linking ISSN: 03022838 NLM ISO Abbreviation: Eur Urol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1873-7560
DOI:10.1016/j.eururo.2014.01.003